Article
Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b.
Journal of medical virology - 1 Feb 2018
Ogasawara Nobuhiko, Kobayashi Masahiro, Akuta Norio, Kominami Yoko, Fujiyama Shunichiro, Kawamura Yusuke, Sezaki Hitomi, Hosaka Tetsuya, Suzuki Fumitaka, Saitoh Satoshi, Suzuki Yoshiyuki, Arase Yasuji, Ikeda Kenji, Kobayashi Mariko, Kumada Hiromitsu
Abstract excerpt
Little information is available on the impact of direct-acting antiviral (DAA) therapy on changes in liver fibrosis and steatosis. Liver stiffness (LS) and controlled attenuation parameter (CAP) values were evaluated using transient elastography. The study subjects were 214 elderly patients infected with HCV genotype 1b who received 24-week daclatasvir and asunaprevir dual therapy. All patients of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
